Anadys Pharmaceuticals

James T. Glover has been appointed to the new position of senior vice president of operations and chief financial officer, Anadys Pharmaceuticals. He will be responsible for Anadys’ operational and financial activities and will report to Kleanthis G. Xanthopoulos, Ph.D., president and chief executive officer.

Mr. Glover joins the company from Beckman Coulter, Inc., where he served as senior vice president and chief financial officer since 2003. During his 23-year tenure at Beckman Coulter, he was responsible for numerous finance activities.

“I am very pleased to welcome Jim to Anadys’ experienced management team,” said Dr. Xanthopoulos. “His financial knowledge and experience, as well as his operational management skills, are exceptional. I am confident that he will make an outstanding contribution at Anadys in the years ahead.”

“I am delighted to become a member of the Anadys team,” said Mr. Glover. “During my meetings and conversations with the senior management and board members of Anadys, I’ve been impressed with the strength of the company’s dedication to developing innovative and powerful medicines for viral diseases and cancer. I look forward to contributing to that vision and commitment.”